Quince Therapeutics
QNCX
#8675
Rank
โ‚น16.57 B
Marketcap
โ‚น297.76
Share price
-4.97%
Change (1 day)
132.71%
Change (1 year)

Quince Therapeutics (QNCX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น9.97 Billion

According to Quince Therapeutics's latest financial reports the company's total liabilities are โ‚น9.97 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Quince Therapeutics - Total liabilities on balance sheet (from 2018 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น7.23 B4.93%
2023-12-31โ‚น6.89 B2411.76%
2022-12-31โ‚น0.27 B-74.81%
2021-12-31โ‚น1.08 B-13.38%
2020-12-31โ‚น1.25 B98.42%
2019-12-31โ‚น0.63 B-91.4%
2018-12-31โ‚น7.37 B312.66%
2017-12-31โ‚น1.78 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น2.22 B-77.70%๐Ÿ‡บ๐Ÿ‡ธ USA